News | May 06, 2024
Zydus Wellness launches pilot for ready-to-drink beverage Glucon-D Activors
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
Cellares will dedicate multiple Cell Shuttle and Cell Q systems with fully automated, high-throughput quality control for Bristol Myers Squibb’s exclusive use
NULIBRY is a first-in-class synthetic cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A
US FDA and EMA accepted filings based on the data from OCARINA II, with EU approval anticipated mid-2024 and U.S. approval anticipated September 2024
The exclusive agreement between AAHI and Croda includes a collaborative effort in research and development
Highly effective preservation solutions ensuring the safety and protection of personal care products
Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine
New leadership team announced at NATHEALTH Annual General Meeting 2024
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
Subscribe To Our Newsletter & Stay Updated
